The PAPI-1 pathogenicity island-encoded small RNA PesA influences Pseudomonas aeruginosa virulence and modulates pyocin S3 production

Silvia Ferrara; Marilena Falcone; Raffaella Macchi; Alessandra Bragonzi; Daniela Girelli; Lisa Cariani; Cristina Cigana; Giovanni Bertoni

doi:10.1371/journal.pone.0180386

Abstract

Small non-coding RNAs (sRNAs) are post-transcriptional regulators of gene expression that have been recognized as key contributors to bacterial virulence and pathogenic mechanisms. In this study, we characterized the sRNA PesA of the opportunistic human pathogen Pseudomonas aeruginosa. We show that PesA, which is transcribed within the pathogenicity island PAPI-1 of P. aeruginosa strain PA14, contributes to P. aeruginosa PA14 virulence. In fact, pesA gene deletion resulted in a less pathogenic strain, showing higher survival of cystic fibrosis human bronchial epithelial cells after infection. Moreover, we show that PesA influences positively the expression of pyocin S3 whose genetic locus comprises two structural genes, pyoS3A and pyoS3I, encoding the killing S3A and the immunity S3I proteins, respectively. Interestingly, the deletion of pesA gene results in increased sensitivity to UV irradiation and to the fluoroquinolone antibiotic ciprofloxacin. The degree of UV sensitivity displayed by the PA14 strain lacking PesA is comparable to that of a strain deleted for pyoS3A-I. These results suggest an involvement of pyocin S3 in DNA damage repair and a regulatory role of PesA on this function.

Citation: Ferrara S, Falcone M, Macchi R, Bragonzi A, Girelli D, Cariani L, et al. (2017) The PAPI-1 pathogenicity island-encoded small RNA PesA influences Pseudomonas aeruginosa virulence and modulates pyocin S3 production. PLoS ONE 12(6): e0180386. https://doi.org/10.1371/journal.pone.0180386

Editor: Eric Cascales, Centre National de la Recherche Scientifique, Aix-Marseille Université, FRANCE

Received: March 17, 2017; Accepted: June 14, 2017; Published: June 30, 2017

Copyright: © 2017 Ferrara et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: All relevant data are within the paper and its Supporting Information files.

Funding: This work has been supported by the following grants to GB: European Commission (NABATIVI-223670, EU-FP7-HEALTH-2007-B) and Italian Cystic Fibrosis Research Foundation (FFC#13/2015) with the contribution of Gruppo di Sostegno FFC di Sassari Castelsardo and Delegazione FFC di Boschi Sant’Anna Minerbe and (FFC#14/2016) with the contribution of Delegazione FFC di Reggio Calabria and Gruppo di Sostegno FFC di Vigevano. SF was the recipient of a Postdoctoral Fellowship of the Università degli Studi di Milano. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

Bacterial small RNAs (sRNAs) have been recognized as key contributors to regulatory networks, and have been shown to play critical roles in many intra- and extracellular processes, and in pathogenesis [1–3]. Most sRNAs exert their regulatory function post-transcriptionally, acting by base pairing with the mRNA of their target genes ultimately modulating mRNA translation and/or stability. sRNAs can share extended base complementarity when they are cis-encoded on the opposite strand of the target mRNA, or they can interact with the target mRNA via short and imperfect base pairing, as in the case of trans-encoded sRNAs. The expression of most sRNAs is responsive to environmental stress conditions spanning from iron and oxygen limitation, to oxidative, metabolic/nutrient, pH and cell envelope stresses [4].

In the opportunistic human pathogen Pseudomonas aeruginosa the use of transcriptomics approaches has recently led to the identification of numerous new sRNAs, mostly in the attenuated strain PAO1 and some also in the virulent one PA14 [5–7]. The bacterium P. aeruginosa is known as a major cause of both acute and chronic lung infections in patients belonging to all age groups who are immunocompromised, or who have defective mucociliary clearance, previous epithelial injury or foreign body placement [8]. Lung infections caused by P. aeruginosa can appear as a spectrum of clinical entities ranging from a rapidly fatal pneumonia in a neutropenic patient to a multi-decade bronchitis in patients with cystic fibrosis (CF). The expression of virulence traits in P. aeruginosa is fine-tuned by a dynamic and intricate regulatory network [9],that leads the expression of P. aeruginosa pathogenic functions with a sharp timing. In this scenario, sRNAs can finely contribute to P. aeruginosa ability to quickly adapt to a new environment and manage to persist.

Previously, bioinformatics and approaches such as the pull-down with the RNA chaperone Hfq have been used for identifying novel P. aeruginosa sRNAs but only a small number of them have been characterized functionally, and even less described as being implicated in the regulation of P. aeruginosa virulence [10–17]. Moreover, most of the studies have been performed using the reference strain PAO1, while very little is known about the biological effects of the sRNA mediated regulation in virulent P. aeruginosa strains, such as PA14. Compared to PAO1, the clinical isolate PA14 is significantly more virulent in a wide range of hosts, including mice, the nematode Caenorhabditis elegans, the insect Galleria mellonella, and the plant Arabidopsis thaliana, and has thus become an important reference strain because of its enhanced virulence [18–20]. Generally, PAO1 and PA14 strains share highly conserved genomes, although PA14 possesses a slightly larger one, likely due to horizontal gene transfer resulting in the acquisition of pathogenicity islands (PAIs) [21].

This study focuses on a P. aeruginosa sRNA observed for the first time by a sRNA-sequencing approach [5], in which unique and conserved sRNAs in the P. aeruginosa strains PAO1 and PA14 were revealed. Here, we validated the sRNA with the operative name SPA0021, renamed PesA, as being transcribed from the pathogenicity island PAPI-1, present in PA14 strain, but not in PAO1. In addition, our results display that PesA is expressed in several P. aeruginosa isolates, including environmental and clinical ones isolated from CF patients. Moreover, we show that PesA operates a post-transcriptional regulation of genes involved in S-type pyocin production. Pyocins are narrow-spectrum bacteriocins synthesized by more than 90% of P. aeruginosa strains and presumed to play a role in niche establishment and protection in mixed populations. The pyocin genes are usually located on the P. aeruginosa chromosome and induced by mutagenic agents that cause DNA damage such as mitomycin C and UV irradiations. P. aeruginosa pyocins can be subdivided into insoluble R and F pyocins and soluble S pyocins. S-type pyocins AP41, S1, S2, and S3 are constituted of two components in which the large component carries an endonuclease C-terminal domain responsible for the killing activity that causes cell death by DNA cleavage [22–27], while pyocins S4 and S5 have tRNAse and pore-forming activities, respectively [28, 29]. More recently, also the new S-type pyocin S6, with rRNase activity, has been described functionally [30]. In our study, we show that PesA deletion leads to decreased expression of pyocin S3, associated to increased sensitivity to UV irradiation and to the fluoroquinolone antibiotic ciprofloxacin. Furthermore, PesA is induced by host-environment stimuli such as low oxygen availability and body temperature, suggesting a key role in P. aeruginosa adaptability to different environmental stresses. Finally, we also found that PesA is involved in the regulation of P. aeruginosa PA14 virulence in CF human bronchial epithelial cells. Our results suggest that a PAPI-1-encoded sRNA can contribute to the modulation of the expression of genes outside PAPI-1, and to different aspects of P. aeruginosa pathogenesis during infection.

Materials and methods

Ethics Statement

Study on human P. aeruginosa isolates from Hannover has been approved by the Ethics Commission of Hannover Medical School, Germany [31]. The patients and parents gave oral informed consent before the sample collection. Approval for storing of biological materials was obtained by the Ethics Commission of Hannover Medical School, Germany. The study on human P. aeruginosa isolates from the Regional CF Center of Lombardia (S1 Table) was approved by the Ethical Committees of San Raffaele Scientific Institute and Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Milan, Italy, and written informed consent was obtained from patients enrolled or their parents according to the Ethical Committees rules, in accordance with the laws of the Italian Ministero della Salute (approval #1874/12 and 1084/14).

Bacterial strains and culture conditions

Bacterial strains and plasmids used in this study are listed in S2 Table. E. coli strains were routinely grown in Luria-Bertani broth (LB) at 37°C. P. aeruginosa strains were grown at 37°C in Brain Heart Infusion (BHI) rich medium or in LB at 120 rpm unless otherwise indicated. Carbenicillin and gentamicin were added at 300 and 20 μg/ml, respectively, unless otherwise indicated. For P_BAD induction in vector plasmid pGM931, arabinose was added to a final concentration of 10 mM. Anaerobic batch cultivations of P. aeruginosa and the shift from aerobic to anaerobic conditions were performed in a 800 ml-Biostat-Q system bioreactor (B-Braun) as described previously [17].

Plasmid constructions and mutant generations

Oligonucleotides used in this study are listed in S3 Table. To construct plasmid pGM-pesA, the pesA gene was PCR-amplified from PA14 genomic DNA with oligos 9/10, digested with NcoI-PstI and cloned into the pHERD20T derivative vector pGM931 carrying a transcriptional terminator downstream the multicloning site [32, 33].

Plasmids pBBR1-pyoS3I::sfGFP, pBBR1-leader-pyoS3A::sfGFP, pBBR1-lacZ::pyoS3A-I::sfGFP, and pBBR1-mCherry::pyoS3A-I::sfGFP expressing pyoS3I::sfGFP, pyoS3A::sfGFP, lacZ::pyos3A-I::sfGFP, or mCherry::pyos3A-I::sfGFP translational fusions, respectively under the P_LtetO-1 constitutive promoter were constructed as follows. A DNA fragment including the last 39 codons of the open reading frame of Pyos3A and 36 first codons of PyoS3I was amplified by PCR with oligos 11/12, digested with NsiI-NheI and cloned into the sfGFP reporter vectors pXG10-SF and pXG30-SF [34] giving rise to plasmid pXG10-pyoS3I::sfGFP and pXG30-lacZ::pyoS3A-I::sfGFP, respectively. A DNA fragment including the 278-nt UTR and the first 37 codons of the pyos3A open reading frame was amplified with oligos 13/14 digested with NsiI-NheI and cloned into the sfGFP reporter vectors pXG10-SF giving rise to plasmid pXG10-leader-pyoS3A::sfGFP.

The DNA fragments spanning from the P_LtetO-1 promoter to the end of the GFP reporter gene were amplified by PCR respectively from pXG10-pyo-S3I::sfGFP, pXG30-lacZ::pyoS3A-I::sfGFP and pXG10-leader-pyoS3A::sfGFP with oligos 18/19, digested with ClaI-XbaI and cloned into the low-copy number shuttle vector pBBR1-MCS5 giving rise to constructs pBBR1-pyoS3I::sfGFP, pBBR1-lacZ::pyoS3A-I::sfGFP and pBBR1-leader-pyoS3A::sfGFP, respectively. mCherry gene was amplified by PCR from the pMMR plasmid [35] using primers 15/16, (in which forward primer contained the Shine-Dalgarno sequence, and reverse primer lacked mCherry stop codon sequence), digested with NsiI and cloned into the pXG10-pyoS3I::sfGFP previously digested with NsiI, giving rise to plasmid pXG10-mCherry::pyoS3A-I::sfGFP. The DNA fragment spanning from the P_LtetO-1 promoter to the end of the GFP reporter gene was amplified by PCR using oligos 18/19 digested with ClaI-XbaI and cloned in the pBBR1-MCS5 vector, giving rise to plasmid pBBR1-mCherry::pyoS3A-I::sfGFP. Plasmid pBBR1-mCherry expressing mCherry reporter gene under P_LtetO-1 was constructed as follows. The DNA fragment including the P_LtetO-1 promoter and the mCherry reporter gene was amplified from pBBR1-mCherry::pyoS3A-I::sfGFP using oligos 17/18 (in which reverse primer contained mCherry stop codon). The PCR product was digested with ClaI-XbaI and cloned in the pBBR1-MCS5 vector.

P. aeruginosa mutant in pesA gene was generated by an enhanced method of markeless gene replacement described previously [36] with some modifications to adapt it to P. aeruginosa as described previuosly [17]. PA14 mutant in pesA gene was obtained by allelic exchange with a deletion from—34 to + 140 positions with respect to pesA transcription start site as follows. TS1 region spanning left 533 bp flanking sequence of pesA gene was amplified by PCR with oligos 23/24. TS2 region spanning last 127 nt and right 368 bp flanking sequence of pesA was amplified by PCR with oligos 25/26. PCR amplifications were performed from PA14 genomic DNA. Overlap extension (SOE)-PCR with oligos 23/26 was used to join TS1 and TS2 that carried end complementary regions introduced by 25/26, respectively during their separate PCR amplification [37]. Joined TS1-TS2 DNA fragments were digested with EcoRI-PstI and cloned in CC118 λpir into the poly-linker site of pSEVA612S giving rise to pSEVApa14-ΔpesA.

The TS1-TS2–inserted pSEVApa14-ΔpesA was transferred from E. coli CC118 λpir to PA14, with the assistance of the helper E. coli strain HB101(pRK600) in a conjugative triparental mating. Exconjugant P. aeruginosa clones were selected on M9-citrate with 60 μg ml⁻¹ of gentamicin. Since pSEVA612S derivatives cannot replicate in P. aeruginosa, Gm^R exconjugant clones could appear only by co-integration of the construct in the genome of the recipient strain by homologous recombination between joined TS1-TS2 fragments borne by pSEVA612S and the recipient chromosome. Plasmid pSW-1 was transferred from E. coli DH5α to P. aeruginosa clones bearing genomic co-integrates of pSEVApa14-ΔpesA by triparental mating as above, and pSW-1-recipient P. aeruginosa clones were selected on M9-citrate with 300 μg ml⁻¹ of carbenicillin. Cultures of resulting P. aeruginosa clones carrying pSW-I were grown overnight in LB with 300 μg ml⁻¹ of carbenicillin and then plated on the same medium. Single colonies were screened for loss of gentamicin resistance. Gentamicin-sensitive clones carrying the deleted alleles were then screened by PCR with oligo pairs 27/28 for pesA.

All plasmid constructs and deletion mutant were checked by sequencing with oligos indicated in S3 Table.

RNA isolation and analysis

Total RNA was prepared as described previously [5] from 2–10 ml of bacterial cell cultures. Quality and concentration of the RNA extracted were assessed by a Biospectrometer (Eppendorf). Northern blot analyses were performed as described previously [5]. DNA oligonucleotide probes were 5'-end labeled with [γ-³²P]ATP (PerkinElmer, NEG502A) and T4 polynucleotide kinase (Promega, M4103) according to manufacturer’s instruction. Oligo 1 and 2 were used to probe PesA and 5S RNA, respectively. Treatment with terminator-5’-phosphate-dependent exonuclease was performed in terminator reaction buffer A (Epicentre, TER51020) as described in detail previously [17].

Radioactive bands were acquired after exposure to phosphor screens using a Typhoon^™ 8600 variable mode Imager scanner (GE Healthcare BioSciences) and visualized with imageQuant software (Molecular Dynamics).

Quantitative RT-PCR analysis was performed on total RNA extracted from P. aeruginosa PA14 wild-type and ΔpesA at mid-, late-exponential and stationary phase (OD₆₀₀ of 0.8, 1.6 and 2.7, respectively). cDNA synthesis was performed from 1 μg of total purified RNA using QuantiTect Reverse Transcription Kit (Qiagen). RT-PCRs were performed using QuantiTect SYBR^® Green PCR Kit (Qiagen) and oligo pairs 30/31, 32/33, 34/35 for 16S, pyoS3A and pyoS3I amplification, respectively. The reaction procedure involved incubation at 95°C for 15s and 40 cycles of amplification at 94°C for 15 s, 60°C for 30 s and 72°C for 30s. 16S ribosomal RNA was used as reference.

In vitro and vivo assays of sRNA/mRNA interactions

Electrophoretic Mobility Shift Assay (EMSA) to analyze sRNA/mRNA interactions were performed as described previously [17].

Experiments with fluorescent reporters were carried out as described previously [17]. Fluorescence polarization FP_485/535, fluorescence intensity FI_590/635 and Abs₅₉₅ were measured in a Tecan Infinity PRO 200 reader, using Magellan as data analysis software (Tecan). GFP and mCherry activities were expressed in Arbitrary Units (AU) as ratio FP_485/535/Abs₅₉₅ and FI_590/635/Abs₅₉₅, respectively.

RNA synthesis

RNAs for RNA/RNA interaction assays were prepared by T7 RNA polymerase transcription of gel-purified DNA fragments obtained by PCR as described previously [17]. DNA fragments for PesA RNA and pyoS3A-I mRNA preparations were amplified from P. aeruginosa PA14 genomic DNA with oligo pairs 3/4 and 5/6, respectively. The DNA fragment for RseX RNA was amplified from E. coli C1a genomic DNA with oligos 7/8.

Pyocin S3 spotting assay

Pyocin killing assay was performed using the spotting method as indicated previously [38] with some modifications. 10 μl of filter-sterilized supernatants from cell cultures with OD₆₀₀ of 1 were spotted onto LB 1.5% agar plates. A lawn of the pyocin S3 sensitive P. aeruginosa strain ATCC 27853 containing 5 × 10⁶ cells ml⁻¹ was plated by inclusion into 0.3% soft agar over the dried spots. Plates were incubated overnight at 37°C and checked for the formation of the clearing zone on the spotting site, which is indicative of the pyocin S3 activity.

Antibiotic disk diffusion

Susceptibilities of P. aeruginosa strains to antimicrobial agents were analyzed by disk diffusion measurement. Filter disks (Oxoid, CT0425B, CT0013B, CT0207B, CT0052B, CT0058, CT0010B) were placed on a lawn of 10⁶ CFU/ml bacterial cells plated by inclusion into 0.3% LB agar. Plates were incubated overnight at 37°C and the diameters of the clear zones around the disks were measured.

UV sensitivity assay

UV treatment was performed using a Stratalinker 1800 UV Crosslinker (Stratagene). Cell cultures with an OD₆₀₀ of 1 (corresponding to 8 x 10⁸ CFU/ml) were serially diluted until 10⁻⁷; 3 μl of each dilution were spotted in triplicate onto LB-agar plates, dried, and exposed to increasing amounts of UV radiation, from 0 to 100 J/m². Plates were incubated overnight at 37°C.

Cytotoxicity assays in human CF respiratory cells

IB3-1 cells, an adeno-associated virus-transformed human bronchial epithelial cell line derived from a CF patient (ΔF508/W1282X) and obtained from LGC Promochem, were grown as described previously [39]. Cells were infected with P. aeruginosa strains at a multiplicity of infection (MOI) of 100. Cell viability was evaluated using the CellTiter 96^® Non-Radioactive Cell Proliferation Assay (MTT) kit (Promega, G4000), according to manufacturer’s instructions.

Bacterial isolates analysis

Bacterial isolates were plated on 1.5% BHI-agar plates and grown overnight at 37°C. Culture samples were taken and processed for genomic DNA and total RNA extraction. PAO1 and PA14 strains treated in the same conditions were used as controls. Oligos 9/10 and 37/38 were used for PCR-amplification of the genomic region containing the pesA and 16S (as positive PCR-control) loci, respectively.

Results

The sRNA PesA is encoded in the PAPI-1 and is a processed transcript

The SPA0021 sRNA was identified using a comparative sRNA-seq approach in which 52 P. aeruginosa novel sRNAs have been identified either in the attenuated strain PAO1 or in the virulent one PA14. SPA0021 was validated to be ≈ 260 nt in lengths, and one of the 12 sRNAs whose genetic locus is unique to the PA14 strain [5]. Moreover, SPA0021 was found to be encoded within the pathogenicity island PAPI-1, and because of this property, we renamed it as pathogenicity island-encoded sRNA A (PesA). The pesA gene locates downstream and on the same strand of pilM2 gene (belonging to the type IV B pilus operon pil2), and overlaps the 3’ of PA14_59370 (gene with unknown function) (Fig 1A and 1B). Since a rho-independent transcription terminator was predicted within the PA14_59370 sequence [40]. The cluster of the sRNA-seq reads that mapped upstream the predicted terminator was considered as the 3’ of the pesA gene [5]. The 5’-end was also mapped by the sRNA-seq read-clustering and was in perfect agreement with the size validated by Northern blot [5].

Download:

Fig 1. Genomic context and transcriptional features of P. aeruginosa pesA gene.

A) Schematic overview of the PAPI-1 region of PA14. The pesA gene is indicated as white arrowhead. B) Sequence of the pilM2–PA14_59370 intergenic region of PA14. The pesA sequence is in bold. The 5′-end of PesA is indicated with +1. A predicted Rho-independent transcription terminator is highlighted in black. The predicted stop codons of pilM2 and PA14_59370 are highlighted in gray. C) PesA expression is induced in stationary phase. Wild-type PA14 was inoculated in BHI at an OD₆₀₀ of 0.2 and grown for 20 h at 37°C with agitation. At the indicated OD₆₀₀, culture samples were taken and processed for total RNA extraction and analysis by Northern blot. Black arrow indicates the main band of pesA of ≈ 260 nt; white arrows indicate bands of higher molecular weight of pesA present especially at early exponential phase (OD₆₀₀ = 0.2). D) Northern blot analysis of PesA on 10 μg of total RNA extracted at the end of the exponential growth phase, treated (+) or untreated (−) with terminator 5′-phosphate-dependent exonuclease (T-ex).

https://doi.org/10.1371/journal.pone.0180386.g001

We evaluated PesA expression along the growth-curve in the rich medium BHI (Fig 1C). Northern blot analyses showed a main band of the expected product size of ≈ 260 nt (black arrow) at each analyzed time point, and multiple bands with higher molecular weight (white arrows) especially at early exponential phase (OD₆₀₀ = 0.2). The main band of PesA showed to accumulate in late stationary phase. The presence of high molecular weight multiple bands, and the absence of rho-independent transcription terminators downstream pilM2, suggested that the main band of ≈ 260 nt could derive from the processing of a longer transcript. Sensitivity to treatment with terminator 5′-phosphate-dependent exonuclease (Fig 1D), which preferentially degrades monophosphate processed transcripts confirmed that the ≈ 260 nt RNA is indeed a processed product.

PesA is widespread expressed in clinical and environmental isolates

To assess the clinical impact of PesA, we validated its presence and expression levels throughout a collection of 29 clinical P. aeruginosa isolates derived from respiratory samples of patients with chronic respiratory diseases, including CF and chronic obstructive pulmonary disease (COPD), and 5 isolates from environmental habitats. In particular, the clinical isolates were recovered both during intermittent infections and at different stages of chronic lung infection. Part of them was previously characterized both in vitro and in vivo [31, 41]. We also included in this study the Liverpool epidemic strain LESB58 [42] and PAO1 and PA14 as controls.

In Fig 2, results on pesA-gene amplification and Northern blot analysis show that the pesA gene is present in 17 out of the 27 CF clinical isolates, in the 2 COPD isolates and in 2 out of 5 environmental isolates. Notably, there was no association between the presence/expression of pesA gene and the P. aeruginosa status (chronic vs intermittent). In addition, no differences were observed between clonal isolates recovered from the same patients at different stages of chronic infection (e.g. AA2-early, AA43-late, AA44-late or TR1-early, TR66-late, TR67-late). In the BHI-plate aerobic growth conditions of these experiments, the majority of the pesA-harboring isolates showed levels of expression similar to those of the PA14 strain or even higher (panel A, lanes 5–7, 11 and 12; panel B, lanes 1, 2, 4, 5, 9, 10; panel C, lanes 2–5, 8 and 10), while 5 isolates showed lower or no expression levels with respect to the PA14 (panel B, lanes 6 and 12; panel C, lanes 1, 6 and 11). In the case of PAO1 and LESB58 strains, no gene amplification was observed (panel A, lanes 4 and 13).

Download:

Fig 2. PesA gene dissemination and expression levels among environmental, CF and COPD clinical isolates.

Assays on environmental, CF and COPD isolates are shown in three panels, A, B and C, respectively. The strain-collection was plated on BHI-agar plates. After overnight growth at 37°C, culture samples were taken and processed for total RNA extraction and analysis by Northern blot, and for genomic DNA extraction. Positive or negative PCR-amplification outcomes are indicated as “+” or “-” in the “pesA gene amplification” row, below each Northern Blot. PAO1 and PA14 were used as controls of Northern Blot analysis and for negative or positive gene amplification, respectively.

https://doi.org/10.1371/journal.pone.0180386.g002

PesA is induced in anaerobic growth and at 37°C

We analyzed the transcriptional responsiveness of PesA RNA to environmental or body temperature, and reduced oxygen availability. Temperature sensitivity was tested by probing PesA in early- (OD₆₀₀ = 0.8) and mid-exponential phase (OD₆₀₀ = 1.8) at both 20 and 37°C and after 20 min of acclimation following a shift from 20 to 37°C, as described in detail previously [17]. As shown in Fig 3A, the growth at 37°C caused an up-regulation of PesA if compared to the growth at 20°C; no increase of PesA RNA accumulation was observed during the 20 min of acclimation. PesA showed also to be responsive to oxygen availability. PesA was probed at mid- and late-exponential phase (OD₆₀₀ of 0.8 and 2, respectively) under anaerobic conditions in BHI with nitrate to sustain anaerobic respiration, as described previously [17]. In addition, bacterial cells were grown in BHI with aeration until mid-exponential phase (OD₆₀₀ = 0.8); then, oxygen was excluded from cultures. PesA levels were assessed immediately before oxygen exclusion and 20 (OD₆₀₀ = 0.9) and 150 min (OD₆₀₀ = 1.3) from the start of anaerobic conditions, as described previously [17]. PesA levels were higher in anaerobic than aerobic conditions both in mid- and late-exponential phase (Fig 3B). In addition, the shift from aerobic to anaerobic conditions caused a progressive increase of PesA levels.

Download:

Fig 3. PesA expression is induced by temperature and low availability of oxygen.

Levels of PesA RNA in: A) Wild-type PA14 grown in BHI at 20°C (lanes 1 and 4), 37°C (lanes 3 and 6) or following 20 min of acclimation (AC) from 20 to 37°C (lanes 2 and 5). Culture samples were taken at middle (OD₆₀₀ of 0.8) and late (OD₆₀₀ of 1.8) exponential growth phase. B) Wild-type PA14 grown in BHI anaerobically (NO₃⁻; lanes 1 and 2), aerobically (O₂, lane 6) and aerobically until an OD₆₀₀ of 0.8 and then shifted to anaerobic conditions (O₂ → NO₃⁻; lanes 3, 4 and 5). Samples were taken 20 and 150 min after the shift to anaerobic conditions (t₂₀ and t₁₅₀). After sampling, cell cultures were processed for total RNA extraction and analysis by Northern blot. Intensities of the bands of PesA were quantified and normalized to those of 5S RNA in the same lane. Values are expressed as arbitrary units (AU) in the histograms below each Northern blot and represent the mean ± Standard Deviation (SD) of three independent experiments.

https://doi.org/10.1371/journal.pone.0180386.g003

PesA is involved in ciprofloxacin and UV-resistance

To explore the involvement of PesA in the regulation of cellular mechanisms, also linked to P. aeruginosa virulence, we constructed the knock-out mutant strain PA14 ΔpesA and the plasmid vector pGM-pesA carrying the pesA gene under the arabinose inducible P_BAD promoter with the aim to measure the effects of perturbing PesA levels on phenotypic traits of the PA14 strain. Deletion of the pesA gene and overexpression from the pGM-pesA vector in the wild-type background were ensured by Northern blot (S1 Fig).

We performed different types of phenotype evaluations. The most evident effects of PesA deletion were on UV and ciprofloxacin susceptibility. In particular, PesA deletion resulted in an enhanced sensitivity to the antibiotic ciprofloxacin and to UV irradiation. In fact, the susceptibility of wild-type PA14 and ΔpesA mutant cells to antimicrobials was analyzed by antibiotic disk diffusion on agar plates. The diameters of the inhibitory zones were measured after overnight incubation at 37°C. As shown in Fig 4, the diameter of the clear zone around ciprofloxacin was higher for mutant ΔpesA (46.33 ±0.58 mm) in comparison to that of wild-type strain (40.33 ± 0.58 mm) thus suggesting a contribution of PesA in the ciprofloxacin resistance mechanism. In addition, we noticed an incremented sensitivity of the ΔpesA mutant strain to UV light, showing a decrease in CFUs with respect to the wild-type starting from treatment with 30 J/m² (Fig 5). This suggested the involvement of PesA in improving survival under conditions of genotoxic stress, such as UV irradiation treatment. Intriguingly, the deletion of pyoS3A-I operon, that is positively regulated by PesA (see below), gave rise to same levels of UV sensitivity as pesA deletion (Fig 5).

Download:

Fig 4. PesA deletion enhances sensitivity to ciprofloxacin.

Antibiotic disk diffusion was performed on LB-agar plates spread with 10⁶ CFU bacterial cells of wild-type PA14 and ΔpesA mutant strains. The diameters of the inhibitory zones were measured after overnight incubation at 37°C. Data derive from three independent experiments. Values represent the mean ± SD. Statistical significance by Student’s t-Test is indicated: **p< 0.01.

https://doi.org/10.1371/journal.pone.0180386.g004

Download:

Fig 5. PesA deletion enhances UV sensitivity similarly to pyoS3 operon deletion.

3 μl of cultures of PA14 wt, ΔpesA and ΔpyoS3, serially diluted 10-fold, were spotted onto LB-agar plates, and treated with UV light at the indicated doses. Surviving CFUs were observed after overnight incubation at 37°C.

https://doi.org/10.1371/journal.pone.0180386.g005

We did not observe significant differences for other phenotypes analyzed, including growth-curves analysis on rich and minimal media, susceptibility to other antimicrobial agents of different structural families, hemolytic activity, flagellum-mediated motility, pyocyanin and pyoverdine secretion.

PesA is involved in P. aeruginosa pathogenicity in human CF respiratory cells

We evaluated the virulence of P. aeruginosa PA14 strains on the CF bronchial epithelial cell line IB3-1. In particular, we assessed the killing capacity of PA14 ΔpesA mutant compared to the wild-type strain by the MTT assay, which provides a method of determining viable cell number measuring the conversion of 3-(4,5-dimethylthiazol)-2,5-diphenyltetrazolium bromide (MTT) to insoluble formazan by dehydrogenase enzymes of the intact mitochondria of living cells. Our results (Fig 6) showed that cells infected with P. aeruginosa PA14 ΔpesA mutant were more viable with respect to those infected by the wild-type strain, thus indicating that pesA may contribute to P. aeruginosa PA14 acute virulence.

Download:

Fig 6. Time course of cell viability of IB3-1 cells following bacterial infection with P. aeruginosa PA14 wild-type and ΔpesA.

Cell viability, assessed as a reduction of MTT salt, was quantified by the optical density (OD) at 490 nm. IB3-1 cells were seeded at a density of 5 × 10⁴ cells/well into 96-well microplates, and infected with 5 × 10⁶ bacterial cells (MOI 1:100). At every time point, data are shown as the difference in OD₄₉₀ between the PA14 wild-type strain and the sRNA-deleted mutant ΔpesA. Uninfected cells were used as positive control of cell viability. Data derive from three independent experiments. Results are shown as the difference in the OD₄₉₀ reached at the different time points by IB3-1 cells infected by the mutant strain or non-infected, subtracted of the OD₄₉₀ reached by IB3-cells infected with the wild-type strain. Values represent the mean ± standard error of the mean (SEM). Statistical significance between wild-type and ΔpesA strains by Student’s t-Test is indicated: *p< 0.05.

https://doi.org/10.1371/journal.pone.0180386.g006

PesA targets pyoS3A-I operon

As mentioned previously, PesA is encoded in cis to the 3’ of the gene PA14_59370 with unknown function, which makes the study of such putative target difficult to perform. Therefore, we managed to identify direct targets of PesA RNA by the use of the bioinformatics tool TargetRNA [43]. This tool predicted, as a high-scored output, an interaction in the region from -30 to -8 nt upstream the gene pyoS3I of the pyoS3 operon (Fig 7A and S4 Table), predicted to encode pyocin S3 in the PA14 strain. The pyocin S3 genetic locus comprises two structural genes, pyoS3A (PA14_49520) and pyoS3I (PA14_49510), annotated to encode the killing S3A and the immunity S3I proteins, respectively. To confirm this annotation in PA14, we deleted the pyoS3 operon and tested the pyocin S3 production by the killing assay of the sensitive ATCC 27853 P. aeruginosa strain [27]. As shown in Fig 8, deletion of pyoS3A-I completely abolished the production of pyocin S3 by PA14 strain. Remarkably, PesA deletion resulted in strong reduction of pyocin S3 production, thus suggesting a positive role of PesA on the pyocin S3 production.

Download:

Fig 7. Interaction of PesA with pyoS3A-I mRNA.

A) Prediction by TargetRNA software of the base-pairing interactions between PesA and pyoS3A-I mRNA. B) In vitro interaction between PesA RNA and pyoS3A-I mRNA by an electrophoretic mobility shift assay. Increasing amounts of PesA RNA (0, 0.08, 0.15, and 0.25 pmol; lanes 1–4) or, as a negative control, E. coli RseX RNA (0.25 and 2.5 pmol; lanes 5 and 6) were incubated at 37°C for 20 min with 0.15 pmol radiolabeled pyoS3A-I mRNA and loaded onto a native 6% polyacrylamide gel.

https://doi.org/10.1371/journal.pone.0180386.g007

Download:

Fig 8. PesA deletion impairs the production of pyocin S3.

Plate showing the effects of pyocin S3 present in the filtered supernatants of PA14 wild-type, ΔpesA and ΔpyoS3A-I on the killing of the indicator strain P. aeruginosa ATCC 27853. Drops of 5 μl of filtered supernatants from PA14 wild-type, ΔpesA and ΔpyoS3A-I cultures at OD₆₀₀ = 1 were deposited on Luria-Bertani agar plates. A layer of the indicator strain P. aeruginosa ATCC 27853 was plated over the dried drops by inclusion in 0.7% agar. Plates were incubated overnight at 37°C. Clearer haloes represent inhibition (killing) of the indicator strain by pyocin S3 present in the sedimented supernatants.

https://doi.org/10.1371/journal.pone.0180386.g008

The predicted region of the pyoS3A-I operon targeted by PesA comprises the Ribosome Binding Site (RBS) of the pyoS3I gene, and locates within the ORF of the pyoS3A gene. To assess this predicted PesA-pyoS3 mRNA interaction, PesA RNA and the pyoS3 mRNA region spanning –116 to +108 from pyoS3I translational start site were produced in vitro, mixed and analyzed on native polyacrylamide gels. As shown in Fig 7B, the two RNAs specifically formed a complex.

We generated distinct types of translational fusions to test the effects of PesA on the pyoS3I gene alone and on the pyoS3A-I mRNA. A first reporter plasmid, named pBBR1-lacZ::pyoS3A-I::sfGFP, mimics a bi-cistron under the control of the heterologous constitutive promoter P_LtetO-1. It was obtained by cloning a region of 224 nt, comprehensive of the last 117 nt of the pyos3A gene and the first 108 nt of pyoS3I thus generating a first translational fusion of the reporter F’lacZ with the last 39 codons of pyoS3A, and a second translational fusion of the first 36 codons of pyoS3I gene with sfGFP. GFP activity was assayed in PA14 wild-type and PA14 ΔpesA in the absence and presence of PesA overexpression from pGM-pesA. As shown in Fig 9A, there was an approximately 25% reduction in GFP activity in the PA14 ΔpesA background. In the presence of pGM-pesA overexpressing PesA, in wild-type background, GFP activity increased approximately 30%. These results suggested that PesA positively regulates pyoS3I expression. To test whether translation of pyos3A gene was necessary to have this PesA effects on pyos3I, we generated a second mono-cistronic reporter derivative, pBBR1-pyoS3I::sfGFP, carrying the same pyoS3A-I region as pBBR1-lacZ::pyoS3A-I::sfGFP in which only the pyoS3I gene was translationally fused with sfGFP. GFP analyses confirmed that PesA influence in a positive manner the regulation of pyoS3I in the mono-cistronic construct, with a ~20% increment in GFP activity in the presence of PesA overexpression in the wild-type background, and a ~40% decrease in the PA14 ΔpesA background (Fig 9B). This suggested that the translation of the two genes is not merely and solely coupled and that the effect of PesA on pyoS3I do not require the translation of pyoS3A.

Download:

Fig 9. PesA positively regulates the expression of both the pyoS3A and pyoS3I translational fusions in PA14.

Comparison of the sfGFP and mCherry activities expressed in arbitrary units (AU) resulting from the translational fusion of (A) lacZ::pyos3A-I::sfGFP, (B) pyoS3I::sfGFP and (C) Cherry::pyoS3A-I::sfGFP combined with the control vector (pGM931) or the plasmid overexpressing PesA (pGM-pesA), in PA14 wild-type and PA14 ΔpesA. The strains were grown to an OD₆₀₀ of 1.8 in LB medium supplemented with gentamicin and carbenicillin, to maintain pBBR1- and pGM- plasmids, respectively, and arabinose, to induce PesA overexpression. Cells were harvested and treated for sfGFP and mCherry activity determination by measuring fluorescence polarization FP_485/535 and fluorescence intensity FI_590/635, respectively. sfGFP and mCherry activities are expressed as ratio FP_485/535/Abs₅₉₅ and FI_590/635/Abs₅₉₅, respectively. Data derive from three independent experiments. Values represent the mean ± SD. Statistical significance by Student’s t-Test is indicated: *p<0.05; **p< 0.01.

https://doi.org/10.1371/journal.pone.0180386.g009

To assess the influence of PesA also on the pyoS3A gene, we substituted the sequence coding for the F’LacZ domain in pBBR1-lacZ::pyoS3A-I::sfGFP with the one of the reporter gene mCherry, and monitored simultaneously the activity of both mCherry and sfGFP of the translational fusion mCherry::pyoS3A-S3I::sfGFP. As shown in Fig 9C, the ~50% increase in sfGFP activity followed by PesA overexpression, and the ~25% decrease in the PA14 ΔpesA background reconfirmed the positive regulation exerted by PesA on the pyoS3I gene. mCherry also showed an increase in activity when PesA was overexpressed, suggesting that PesA also exerts a positive regulation on the upstream gene pyoS3A. Thus, PesA seems to be a positive regulator of the whole pyoS3 operon.

Quantitative RT-PCR on total mRNA of wild-type and ΔpesA strains was also performed to check whether PesA influenced pyoS3 mRNA levels. Samples were taken at mid-, late-exponential and stationary phase (OD₆₀₀ of 0.8, 1.6 and 2.7, respectively) and both genes, pyoS3A and pyoS3I, were analyzed for their expression levels. No significant differences were observed either for pyoS3A or pyoS3I in wild-type and ΔpesA backgrounds at any time-point. Notably, the expression levels of the two genes were comparable at every time-point and seemed not to be influenced by the growth phase, being constant along the growth curve (S5 Table). We conclude that PesA exerts positive regulation on pyoS3A-I mRNA by modulating mRNA translatability and without influencing its stability.

By the use of the IntaRNA web tool [44, 45], we also detected a putative interacting region between PesA and the leader sequence of the pyoS3 operon, from -76 to -42 from the TTG start codon of the pyoS3A gene. To evaluate whether PesA was also able to influence the S3-operon translation by acting on its leader sequence, we generated the translational fusion leader-pyoS3A::sfGFP, by cloning the whole leader region of the pyoS3 operon and the sequence encoding the first 37 aminoacids of pyos3A gene, in frame with the sfGFP reporter. The comparison of the fluorescence activity of the leader-pyoS3A::sfGFP translational fusion between the wild-type and ΔpesA genetic background did not show any significant difference, not even in presence of PesA overexpression from pGM-pesA in wild-type (S2 Fig). Spurious outside interactions of PesA with sfGFP and mCherry open reading frame were ruled out using alternative reporter plasmids carrying the sfGFP and mCherry genes alone (S2 Fig).

Discussion

We studied the novel P. aeruginosa sRNA PesA, which was originally identified as being transcribed from the horizontally acquired pathogenicity island PAPI-1 in the strain PA14. Our analysis revealed that PesA is widespread in clinical isolates from patients affected by chronic respiratory diseases, such as CF, being expressed in 55% of the cases tested. Moreover, PesA expression is responsive to low oxygen conditions, a hallmark of CF and COPD, and impacts P. aeruginosa pathogenicity in CF bronchial cells. These results suggest that PesA could be relevant during P. aeruginosa infection in chronic respiratory diseases.

We speculated that PesA had the potential to act as a trans-encoded base-pairing sRNA involved also in the post-transcriptional regulation of genes located outside PAPI-1 and thus performed genome-wide bioinformatics screenings for target genes. One predicted target was the pyoS3A-I operon coding for pyocin S3. We then confirmed that both pyoS3A and pyoS3I genes are positively influenced by PesA. The interaction of PesA with the bicistronic pyoS3A-I mRNA is suggested to simultaneously stimulate translation initiation and termination of pyoS3I and pyoS3A, respectively, without influencing stability of the pyoS3A-I mRNA. Interestingly, PesA could impact a putative mechanism of translation coupling between pyoS3I and pyoS3A [22] that remains to be elucidated. However, in this paper we demonstrate that stimulation of pyoS3I by PesA does not require translation of the upstream pyoS3A thus suggesting that the two genes are not strictly translationally coupled. This scenario, as a whole, is compatible with the role of PesA in assuring balanced expression of toxin S3A and antitoxin S3I to prevent deleterious effects on the producing host. Overall, these data obtained with the reporter genes are consistent with the observation that PesA deletion results in strong reduction of pyocin S3 production (Fig 8).

It is conceivable that PesA can be involved in mechanisms of niche establishment via pyocin S3. PesA was in fact also detected in environmental isolates and its expression from PAPI-1 might confer a selective advantage that favours PAPI-1 maintenance in the environment due to its regulation of pyocin S3.

It is likely that PesA has a broad set of target genes whose functions go beyond the niche establishment. The observation that PesA deletion induces less killing in infected CF bronchial epithelial cells suggests that PesA could modulate, directly or indirectly, virulence factors of P. aeruginosa. It was previously shown that pyocin S2 is endowed with cytotoxic activity on human cell lines [46]. It can be argued that pyocin S3 has similar effects and can act as virulence factor whose regulation is under the control of PesA.

Furthermore, PesA could regulate the expression of genes involved in DNA damage repair as suggested by the increased sensitivity of ΔpesA mutant to fluoroquinolone antibiotic ciprofloxacin and to UV irradiation. Intriguingly, the degree of UV sensitivity displayed by the ΔpesA mutant is comparable to that of a strain deleted for pyoS3A-I. These results imply a potential involvement of the DNase activity of pyocin S3 in DNA damage repair, and introduce an intriguing network among sRNAs, pyocins and DNA damage repair that will require additional experiments to be elucidated. To our knowledge this is the first work characterizing a sRNA encoded in a pathogenicity island in P. aeruginosa. In addition, our results indicate that PesA is able to modulate key genes located outside the PAPI-1. In summary, the horizontal acquisition of PAPI-1 could provide the new host with a regulatory function that can switch the expression of genes involved in niche establishment, virulence and stress resistance.

Supporting information

S1 Fig. Validation of PesA deletion and overexpression.

A) PA14 wild-type and PA14 ΔpesA were grown in BHI medium until an OD₆₀₀ of 2.7. Culture samples were taken and processed for total RNA extraction and analysis by Northern blot. B) PA14 strains harbouring pGM-pesA or the control empty vector pGM931 were grown in BHI medium with carbenicillin until an OD₆₀₀ of 0.8. Cells were split into two flasks, and 10 mM arabinose (ara) was added to one. Culture samples were taken at the indicated OD₆₀₀ and processed for total RNA extraction and analysis by Northern blot probing PesA RNA. Intensities of the bands of PesA were quantified and normalized to those of 5S RNA in the same lane. Values are expressed as arbitrary units (AU) in the histograms below the Northern blot.

https://doi.org/10.1371/journal.pone.0180386.s001

(TIF)

S2 Fig. Fluorescence activity to check PesA regulation on the leader of pyoS3A gene, and spurious outside interactions of PesA with sfGFP and mCherry open reading frames.

A) Comparison of the sfGFP activity resulting from the translational fusion leader-pyoS3A::sfGFP in PA14 wild-type and PA14 ΔpesA (-), and combined with the control vector (pGM931) or the plasmid overexpressing PesA (pGM-pesA) in PA14 wild-type. B) Comparison of the fluorescence activity of the reporter gene sfGFP combined with the control vector (pGM931) or the plasmid overexpressing PesA (pGM-pesA), in PA14 wild-type and PA14 ΔpesA. C) Comparison of fluorescence activity of the reporter gene mCherry combined with the control vector (pGM931) or the plasmid overexpressing PesA (pGM-pesA), PA14 wild-type and PA14 ΔpesA.

https://doi.org/10.1371/journal.pone.0180386.s002

(TIF)

S1 Table. Clinical isolates.

https://doi.org/10.1371/journal.pone.0180386.s003

(PDF)

S2 Table. Strains and plasmids.

https://doi.org/10.1371/journal.pone.0180386.s004

(PDF)

S3 Table. Oligonucleotides.

https://doi.org/10.1371/journal.pone.0180386.s005

(PDF)

S4 Table. List of mRNA targets of PesA predicted by bioinformatics analysis conducted with the TargetRNA web-tool.

https://doi.org/10.1371/journal.pone.0180386.s006

(PDF)

S5 Table. Quantitative RT-PCR analyses of pyoS3A and pyoS3I mRNA levels in wild-type and ΔpesA backgrounds.

https://doi.org/10.1371/journal.pone.0180386.s007

(PDF)

Acknowledgments

The authors would like to thank Prof. B. Tümmler (Hannover Medical School, Hannover, Germany) for supplying the P. aeruginosa strains from CF patients, and Prof. C. Winstanley for providing LESB58 strain.

This work has been supported by the European Commission (NABATIVI-223670, EU-FP7-HEALTH-2007-B) and Italian Cystic Fibrosis Research Foundation (FFC#13/2015) with the contribution of Gruppo di Sostegno FFC di Sassari Castelsardo and Delegazione FFC di Boschi Sant’Anna Minerbe and (FFC#14/2016) with the contribution of Delegazione FFC di Reggio Calabria and Gruppo di Sostegno FFC di Vigevano. S.F. was the recipient of a Postdoctoral Fellowship of the Università degli Studi di Milano. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author Contributions

Conceptualization: SF GB.
Data curation: SF CC MF RM AB GB.
Formal analysis: SF CC.
Funding acquisition: GB.
Investigation: SF MF RM.
Project administration: GB AB.
Resources: DG LC.
Supervision: SF CC AB GB.
Validation: SF CC MF RM AB GB.
Visualization: SF.
Writing – original draft: SF GB CC AB.
Writing – review & editing: SF GB.

References

1. Gottesman S, Storz G. Bacterial small RNA regulators: versatile roles and rapidly evolving variations. Cold Spring Harb Perspect Biol. 2011; 3(12): a003798 pmid:20980440
- View Article
- PubMed/NCBI
- Google Scholar
2. Storz G, Vogel J, Wassarman KM. Regulation by Small RNAs in Bacteria: Expanding Frontiers. Molecular cell. 2011;43(6):880–91. pmid:21925377
- View Article
- PubMed/NCBI
- Google Scholar
3. Caldelari I, Chao Y, Romby P, Vogel J. RNA-mediated regulation in pathogenic bacteria. Cold Spring Harb Perspect Med. 2013;3(9):a010298. pmid:24003243
- View Article
- PubMed/NCBI
- Google Scholar
4. Hoe CH, Raabe CA, Rozhdestvensky TS, Tang TH. Bacterial sRNAs: regulation in stress. Int J Med Microbiol. 2013;303(5):217–29. pmid:23660175
- View Article
- PubMed/NCBI
- Google Scholar
5. Ferrara S, Brugnoli M, De Bonis A, Righetti F, Delvillani F, Deho G, et al. Comparative profiling of Pseudomonas aeruginosa strains reveals differential expression of novel unique and conserved small RNAs. PLoS One. 2012;7(5):e36553. pmid:22590564
- View Article
- PubMed/NCBI
- Google Scholar
6. Gomez-Lozano M, Marvig RL, Molin S, Long KS. Genome-wide identification of novel small RNAs in Pseudomonas aeruginosa. Environ Microbiol. 2012;14(8):2006–16. pmid:22533370
- View Article
- PubMed/NCBI
- Google Scholar
7. Wurtzel O, Yoder-Himes DR, Han K, Dandekar AA, Edelheit S, Greenberg EP, et al. The single-nucleotide resolution transcriptome of Pseudomonas aeruginosa grown in body temperature. PLoS Pathog. 2012;8(9):e1002945. pmid:23028334
- View Article
- PubMed/NCBI
- Google Scholar
8. Wagner VE FM, Picardo KF, Iglewski BH. Pseudomonas aeruginosa virulence and pathogenesis issues. 2008;Norfolk: Caister Academic Press:129–58.
9. Balasubramanian D, Schneper L, Kumari H, Mathee K. A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence. Nucleic Acids Res. 2013;41(1):1–20. pmid:23143271
- View Article
- PubMed/NCBI
- Google Scholar
10. Heurlier K, Williams F, Heeb S, Dormond C, Pessi G, Singer D, et al. Positive control of swarming, rhamnolipid synthesis, and lipase production by the posttranscriptional RsmA/RsmZ system in Pseudomonas aeruginosa PAO1. Journal of bacteriology. 2004;186(10):2936–45. pmid:15126453
- View Article
- PubMed/NCBI
- Google Scholar
11. Wilderman PJ, Sowa NA, FitzGerald DJ, FitzGerald PC, Gottesman S, Ochsner UA, et al. Identification of tandem duplicate regulatory small RNAs in Pseudomonas aeruginosa involved in iron homeostasis. Proceedings of the National Academy of Sciences of the United States of America. 2004;101(26):9792–7. pmid:15210934
- View Article
- PubMed/NCBI
- Google Scholar
12. Sonnleitner E, Sorger-Domenigg T, Madej MJ, Findeiss S, Hackermuller J, Huttenhofer A, et al. Detection of small RNAs in Pseudomonas aeruginosa by RNomics and structure-based bioinformatic tools. Microbiology. 2008;154(Pt 10):3175–87. pmid:18832323
- View Article
- PubMed/NCBI
- Google Scholar
13. Lapouge K, Schubert M, Allain FH, Haas D. Gac/Rsm signal transduction pathway of gamma-proteobacteria: from RNA recognition to regulation of social behaviour. Mol Microbiol. 2008;67(2):241–53. pmid:18047567
- View Article
- PubMed/NCBI
- Google Scholar
14. Sonnleitner E, Gonzalez N, Sorger-Domenigg T, Heeb S, Richter AS, Backofen R, et al. The small RNA PhrS stimulates synthesis of the Pseudomonas aeruginosa quinolone signal. Molecular microbiology. 2011;80(4):868–85. pmid:21375594
- View Article
- PubMed/NCBI
- Google Scholar
15. Sonnleitner E, Blasi U. Regulation of Hfq by the RNA CrcZ in Pseudomonas aeruginosa carbon catabolite repression. PLoS Genet. 2014;10(6):e1004440. pmid:24945892
- View Article
- PubMed/NCBI
- Google Scholar
16. Wenner N, Maes A, Cotado-Sampayo M, Lapouge K. NrsZ: a novel, processed, nitrogen-dependent, small non-coding RNA that regulates Pseudomonas aeruginosa PAO1 virulence. Environ Microbiol. 2014;16(4):1053–68. pmid:24308329
- View Article
- PubMed/NCBI
- Google Scholar
17. Ferrara S, Carloni S, Fulco R, Falcone M, Macchi R, Bertoni G. Post-transcriptional regulation of the virulence-associated enzyme AlgC by the sigma(22) -dependent small RNA ErsA of Pseudomonas aeruginosa. Environ Microbiol. 2015;17(1):199–214. pmid:25186153
- View Article
- PubMed/NCBI
- Google Scholar
18. Choi JY, Sifri CD, Goumnerov BC, Rahme LG, Ausubel FM, Calderwood SB. Identification of virulence genes in a pathogenic strain of Pseudomonas aeruginosa by representational difference analysis. J Bacteriol. 2002;184(4):952–61. pmid:11807055
- View Article
- PubMed/NCBI
- Google Scholar
19. Rahme LG, Stevens EJ, Wolfort SF, Shao J, Tompkins RG, Ausubel FM. Common virulence factors for bacterial pathogenicity in plants and animals. Science. 1995;268(5219):1899–902. pmid:7604262
- View Article
- PubMed/NCBI
- Google Scholar
20. Belanger M, Burrows LL, Lam JS. Functional analysis of genes responsible for the synthesis of the B-band O antigen of Pseudomonas aeruginosa serotype O6 lipopolysaccharide. Microbiology. 1999;145 (Pt 12):3505–21.
- View Article
- Google Scholar
21. Lee DG, Urbach JM, Wu G, Liberati NT, Feinbaum RL, Miyata S, et al. Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial. Genome Biol. 2006;7(10):R90. pmid:17038190
- View Article
- PubMed/NCBI
- Google Scholar
22. Duport C, Baysse C, Michel-Briand Y. Molecular characterization of pyocin S3, a novel S-type pyocin from Pseudomonas aeruginosa. J Biol Chem. 1995;270(15):8920–7. pmid:7721800
- View Article
- PubMed/NCBI
- Google Scholar
23. Sano Y, Kageyama M. A novel transposon-like structure carries the genes for pyocin AP41, a Pseudomonas aeruginosa bacteriocin with a DNase domain homology to E2 group colicins. Mol Gen Genet. 1993;237(1–2):161–70. pmid:8384291
- View Article
- PubMed/NCBI
- Google Scholar
24. Sano Y, Kobayashi M, Kageyama M. Functional domains of S-type pyocins deduced from chimeric molecules. J Bacteriol. 1993;175(19):6179–85. pmid:8407790
- View Article
- PubMed/NCBI
- Google Scholar
25. Sano Y, Matsui H, Kobayashi M, Kageyama M. Molecular structures and functions of pyocins S1 and S2 in Pseudomonas aeruginosa. J Bacteriol. 1993;175(10):2907–16. pmid:8491711
- View Article
- PubMed/NCBI
- Google Scholar
26. Seo Y, Galloway DR. Purification of the pyocin S2 complex from Pseudomonas aeruginosa PAO1: analysis of DNase activity. Biochem Biophys Res Commun. 1990;172(2):455–61. pmid:2122894
- View Article
- PubMed/NCBI
- Google Scholar
27. Baysse C, Meyer JM, Plesiat P, Geoffroy V, Michel-Briand Y, Cornelis P. Uptake of pyocin S3 occurs through the outer membrane ferripyoverdine type II receptor of Pseudomonas aeruginosa. J Bacteriol. 1999;181(12):3849–51. pmid:10368165
- View Article
- PubMed/NCBI
- Google Scholar
28. Elfarash A, Wei Q, Cornelis P. The soluble pyocins S2 and S4 from Pseudomonas aeruginosa bind to the same FpvAI receptor. Microbiologyopen. 2012;1(3):268–75. pmid:23170226
- View Article
- PubMed/NCBI
- Google Scholar
29. Ling H, Saeidi N, Rasouliha BH, Chang MW. A predicted S-type pyocin shows a bactericidal activity against clinical Pseudomonas aeruginosa isolates through membrane damage. FEBS Lett. 2010;584(15):3354–8. pmid:20580355
- View Article
- PubMed/NCBI
- Google Scholar
30. Dingemans J, Ghequire MG, Craggs M, De Mot R, Cornelis P. Identification and functional analysis of a bacteriocin, pyocin S6, with ribonuclease activity from a Pseudomonas aeruginosa cystic fibrosis clinical isolate. Microbiologyopen. 2016. 5(3):413–23. pmid:26860427.
- View Article
- PubMed/NCBI
- Google Scholar
31. Bragonzi A, Paroni M, Nonis A, Cramer N, Montanari S, Rejman J, et al. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. American journal of respiratory and critical care medicine. 2009;180(2):138–45. pmid:19423715
- View Article
- PubMed/NCBI
- Google Scholar
32. Qiu D, Damron FH, Mima T, Schweizer HP, Yu HD. PBAD-based shuttle vectors for functional analysis of toxic and highly regulated genes in Pseudomonas and Burkholderia spp. and other bacteria. Appl Environ Microbiol. 2008;74(23):7422–6. pmid:18849445
- View Article
- PubMed/NCBI
- Google Scholar
33. Delvillani F, Sciandrone B, Peano C, Petiti L, Berens C, Georgi C, et al. Tet-Trap, a genetic approach to the identification of bacterial RNA thermometers: application to Pseudomonas aeruginosa. RNA. 2014;20(12):1963–76. pmid:25336583
- View Article
- PubMed/NCBI
- Google Scholar
34. Corcoran CP, Podkaminski D, Papenfort K, Urban JH, Hinton JC, Vogel J. Superfolder GFP reporters validate diverse new mRNA targets of the classic porin regulator, MicF RNA. Mol Microbiol. 2012;84(3):428–45. pmid:22458297
- View Article
- PubMed/NCBI
- Google Scholar
35. Popat R, Crusz SA, Messina M, Williams P, West SA, Diggle SP. Quorum-sensing and cheating in bacterial biofilms. Proc Biol Sci. 2012;279(1748):4765–71. pmid:23034707
- View Article
- PubMed/NCBI
- Google Scholar
36. Martinez-Garcia E, de Lorenzo V. Engineering multiple genomic deletions in Gram-negative bacteria: analysis of the multi-resistant antibiotic profile of Pseudomonas putida KT2440. Environ Microbiol. 2011;13(10):2702–16. pmid:21883790
- View Article
- PubMed/NCBI
- Google Scholar
37. Horton RM, Hunt HD, Ho SN, Pullen JK, Pease LR. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene. 1989;77(1):61–8. pmid:2744488
- View Article
- PubMed/NCBI
- Google Scholar
38. Fyfe JA, Harris G, Govan JR. Revised pyocin typing method for Pseudomonas aeruginosa. J Clin Microbiol. 1984;20(1):47–50. pmid:6430955
- View Article
- PubMed/NCBI
- Google Scholar
39. Cigana C, Curcuru L, Leone MR, Ierano T, Lore NI, Bianconi I, et al. Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection. PLoS One. 2009;4(12):e8439. pmid:20037649
- View Article
- PubMed/NCBI
- Google Scholar
40. Winsor GL, Griffiths EJ, Lo R, Dhillon BK, Shay JA, Brinkman FS. Enhanced annotations and features for comparing thousands of Pseudomonas genomes in the Pseudomonas genome database. Nucleic Acids Res. 2016; 44(D1):D646–53. pmid:26578582
- View Article
- PubMed/NCBI
- Google Scholar
41. Cigana C, Lore NI, Riva C, De Fino I, Spagnuolo L, Sipione B, et al. Tracking the immunopathological response to Pseudomonas aeruginosa during respiratory infections. Sci Rep. 2016;6:21465. pmid:26883959
- View Article
- PubMed/NCBI
- Google Scholar
42. Kukavica-Ibrulj I, Bragonzi A, Paroni M, Winstanley C, Sanschagrin F, O'Toole GA, et al. In vivo growth of Pseudomonas aeruginosa strains PAO1 and PA14 and the hypervirulent strain LESB58 in a rat model of chronic lung infection. Journal of bacteriology. 2008;190(8):2804–13. pmid:18083816
- View Article
- PubMed/NCBI
- Google Scholar
43. Tjaden B. TargetRNA: a tool for predicting targets of small RNA action in bacteria. Nucleic Acids Res. 2008;36.
- View Article
- Google Scholar
44. Wright PR, Georg J, Mann M, Sorescu DA, Richter AS, Lott S, et al. CopraRNA and IntaRNA: predicting small RNA targets, networks and interaction domains. Nucleic Acids Res. 2014;42.
- View Article
- Google Scholar
45. Busch A, Richter AS, Backofen R. IntaRNA: efficient prediction of bacterial sRNA targets incorporating target site accessibility and seed regions. Bioinformatics. 2008;24(24):2849–56. pmid:18940824
- View Article
- PubMed/NCBI
- Google Scholar
46. Abdi-Ali A, Worobec EA, Deezagi A, Malekzadeh F. Cytotoxic effects of pyocin S2 produced by Pseudomonas aeruginosa on the growth of three human cell lines. Can J Microbiol. 2004;50(5):375–81. pmid:15213746
- View Article
- PubMed/NCBI
- Google Scholar

[ref1] 1. Gottesman S, Storz G. Bacterial small RNA regulators: versatile roles and rapidly evolving variations. Cold Spring Harb Perspect Biol. 2011; 3(12): a003798 pmid:20980440
View Article
PubMed/NCBI
Google Scholar

[2] View Article

[3] PubMed/NCBI

[4] Google Scholar

[ref2] 2. Storz G, Vogel J, Wassarman KM. Regulation by Small RNAs in Bacteria: Expanding Frontiers. Molecular cell. 2011;43(6):880–91. pmid:21925377
View Article
PubMed/NCBI
Google Scholar

[6] View Article

[7] PubMed/NCBI

[8] Google Scholar

[ref3] 3. Caldelari I, Chao Y, Romby P, Vogel J. RNA-mediated regulation in pathogenic bacteria. Cold Spring Harb Perspect Med. 2013;3(9):a010298. pmid:24003243
View Article
PubMed/NCBI
Google Scholar

[10] View Article

[11] PubMed/NCBI

[12] Google Scholar

[ref4] 4. Hoe CH, Raabe CA, Rozhdestvensky TS, Tang TH. Bacterial sRNAs: regulation in stress. Int J Med Microbiol. 2013;303(5):217–29. pmid:23660175
View Article
PubMed/NCBI
Google Scholar

[14] View Article

[15] PubMed/NCBI

[16] Google Scholar

[ref5] 5. Ferrara S, Brugnoli M, De Bonis A, Righetti F, Delvillani F, Deho G, et al. Comparative profiling of Pseudomonas aeruginosa strains reveals differential expression of novel unique and conserved small RNAs. PLoS One. 2012;7(5):e36553. pmid:22590564
View Article
PubMed/NCBI
Google Scholar

[18] View Article

[19] PubMed/NCBI

[20] Google Scholar

[ref6] 6. Gomez-Lozano M, Marvig RL, Molin S, Long KS. Genome-wide identification of novel small RNAs in Pseudomonas aeruginosa. Environ Microbiol. 2012;14(8):2006–16. pmid:22533370
View Article
PubMed/NCBI
Google Scholar

[22] View Article

[23] PubMed/NCBI

[24] Google Scholar

[ref7] 7. Wurtzel O, Yoder-Himes DR, Han K, Dandekar AA, Edelheit S, Greenberg EP, et al. The single-nucleotide resolution transcriptome of Pseudomonas aeruginosa grown in body temperature. PLoS Pathog. 2012;8(9):e1002945. pmid:23028334
View Article
PubMed/NCBI
Google Scholar

[26] View Article

[27] PubMed/NCBI

[28] Google Scholar

[ref8] 8. Wagner VE FM, Picardo KF, Iglewski BH. Pseudomonas aeruginosa virulence and pathogenesis issues. 2008;Norfolk: Caister Academic Press:129–58.

[ref9] 9. Balasubramanian D, Schneper L, Kumari H, Mathee K. A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence. Nucleic Acids Res. 2013;41(1):1–20. pmid:23143271
View Article
PubMed/NCBI
Google Scholar

[31] View Article

[32] PubMed/NCBI

[33] Google Scholar

[ref10] 10. Heurlier K, Williams F, Heeb S, Dormond C, Pessi G, Singer D, et al. Positive control of swarming, rhamnolipid synthesis, and lipase production by the posttranscriptional RsmA/RsmZ system in Pseudomonas aeruginosa PAO1. Journal of bacteriology. 2004;186(10):2936–45. pmid:15126453
View Article
PubMed/NCBI
Google Scholar

[35] View Article

[36] PubMed/NCBI

[37] Google Scholar

[ref11] 11. Wilderman PJ, Sowa NA, FitzGerald DJ, FitzGerald PC, Gottesman S, Ochsner UA, et al. Identification of tandem duplicate regulatory small RNAs in Pseudomonas aeruginosa involved in iron homeostasis. Proceedings of the National Academy of Sciences of the United States of America. 2004;101(26):9792–7. pmid:15210934
View Article
PubMed/NCBI
Google Scholar

[39] View Article

[40] PubMed/NCBI

[41] Google Scholar

[ref12] 12. Sonnleitner E, Sorger-Domenigg T, Madej MJ, Findeiss S, Hackermuller J, Huttenhofer A, et al. Detection of small RNAs in Pseudomonas aeruginosa by RNomics and structure-based bioinformatic tools. Microbiology. 2008;154(Pt 10):3175–87. pmid:18832323
View Article
PubMed/NCBI
Google Scholar

[43] View Article

[44] PubMed/NCBI

[45] Google Scholar

[ref13] 13. Lapouge K, Schubert M, Allain FH, Haas D. Gac/Rsm signal transduction pathway of gamma-proteobacteria: from RNA recognition to regulation of social behaviour. Mol Microbiol. 2008;67(2):241–53. pmid:18047567
View Article
PubMed/NCBI
Google Scholar

[47] View Article

[48] PubMed/NCBI

[49] Google Scholar

[ref14] 14. Sonnleitner E, Gonzalez N, Sorger-Domenigg T, Heeb S, Richter AS, Backofen R, et al. The small RNA PhrS stimulates synthesis of the Pseudomonas aeruginosa quinolone signal. Molecular microbiology. 2011;80(4):868–85. pmid:21375594
View Article
PubMed/NCBI
Google Scholar

[51] View Article

[52] PubMed/NCBI

[53] Google Scholar

[ref15] 15. Sonnleitner E, Blasi U. Regulation of Hfq by the RNA CrcZ in Pseudomonas aeruginosa carbon catabolite repression. PLoS Genet. 2014;10(6):e1004440. pmid:24945892
View Article
PubMed/NCBI
Google Scholar

[55] View Article

[56] PubMed/NCBI

[57] Google Scholar

[ref16] 16. Wenner N, Maes A, Cotado-Sampayo M, Lapouge K. NrsZ: a novel, processed, nitrogen-dependent, small non-coding RNA that regulates Pseudomonas aeruginosa PAO1 virulence. Environ Microbiol. 2014;16(4):1053–68. pmid:24308329
View Article
PubMed/NCBI
Google Scholar

[59] View Article

[60] PubMed/NCBI

[61] Google Scholar

[ref17] 17. Ferrara S, Carloni S, Fulco R, Falcone M, Macchi R, Bertoni G. Post-transcriptional regulation of the virulence-associated enzyme AlgC by the sigma(22) -dependent small RNA ErsA of Pseudomonas aeruginosa. Environ Microbiol. 2015;17(1):199–214. pmid:25186153
View Article
PubMed/NCBI
Google Scholar

[63] View Article

[64] PubMed/NCBI

[65] Google Scholar

[ref18] 18. Choi JY, Sifri CD, Goumnerov BC, Rahme LG, Ausubel FM, Calderwood SB. Identification of virulence genes in a pathogenic strain of Pseudomonas aeruginosa by representational difference analysis. J Bacteriol. 2002;184(4):952–61. pmid:11807055
View Article
PubMed/NCBI
Google Scholar

[67] View Article

[68] PubMed/NCBI

[69] Google Scholar

[ref19] 19. Rahme LG, Stevens EJ, Wolfort SF, Shao J, Tompkins RG, Ausubel FM. Common virulence factors for bacterial pathogenicity in plants and animals. Science. 1995;268(5219):1899–902. pmid:7604262
View Article
PubMed/NCBI
Google Scholar

[71] View Article

[72] PubMed/NCBI

[73] Google Scholar

[ref20] 20. Belanger M, Burrows LL, Lam JS. Functional analysis of genes responsible for the synthesis of the B-band O antigen of Pseudomonas aeruginosa serotype O6 lipopolysaccharide. Microbiology. 1999;145 (Pt 12):3505–21.
View Article
Google Scholar

[75] View Article

[76] Google Scholar

[ref21] 21. Lee DG, Urbach JM, Wu G, Liberati NT, Feinbaum RL, Miyata S, et al. Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial. Genome Biol. 2006;7(10):R90. pmid:17038190
View Article
PubMed/NCBI
Google Scholar

[78] View Article

[79] PubMed/NCBI

[80] Google Scholar

[ref22] 22. Duport C, Baysse C, Michel-Briand Y. Molecular characterization of pyocin S3, a novel S-type pyocin from Pseudomonas aeruginosa. J Biol Chem. 1995;270(15):8920–7. pmid:7721800
View Article
PubMed/NCBI
Google Scholar

[82] View Article

[83] PubMed/NCBI

[84] Google Scholar

[ref23] 23. Sano Y, Kageyama M. A novel transposon-like structure carries the genes for pyocin AP41, a Pseudomonas aeruginosa bacteriocin with a DNase domain homology to E2 group colicins. Mol Gen Genet. 1993;237(1–2):161–70. pmid:8384291
View Article
PubMed/NCBI
Google Scholar

[86] View Article

[87] PubMed/NCBI

[88] Google Scholar

[ref24] 24. Sano Y, Kobayashi M, Kageyama M. Functional domains of S-type pyocins deduced from chimeric molecules. J Bacteriol. 1993;175(19):6179–85. pmid:8407790
View Article
PubMed/NCBI
Google Scholar

[90] View Article

[91] PubMed/NCBI

[92] Google Scholar

[ref25] 25. Sano Y, Matsui H, Kobayashi M, Kageyama M. Molecular structures and functions of pyocins S1 and S2 in Pseudomonas aeruginosa. J Bacteriol. 1993;175(10):2907–16. pmid:8491711
View Article
PubMed/NCBI
Google Scholar

[94] View Article

[95] PubMed/NCBI

[96] Google Scholar

[ref26] 26. Seo Y, Galloway DR. Purification of the pyocin S2 complex from Pseudomonas aeruginosa PAO1: analysis of DNase activity. Biochem Biophys Res Commun. 1990;172(2):455–61. pmid:2122894
View Article
PubMed/NCBI
Google Scholar

[98] View Article

[99] PubMed/NCBI

[100] Google Scholar

[ref27] 27. Baysse C, Meyer JM, Plesiat P, Geoffroy V, Michel-Briand Y, Cornelis P. Uptake of pyocin S3 occurs through the outer membrane ferripyoverdine type II receptor of Pseudomonas aeruginosa. J Bacteriol. 1999;181(12):3849–51. pmid:10368165
View Article
PubMed/NCBI
Google Scholar

[102] View Article

[103] PubMed/NCBI

[104] Google Scholar

[ref28] 28. Elfarash A, Wei Q, Cornelis P. The soluble pyocins S2 and S4 from Pseudomonas aeruginosa bind to the same FpvAI receptor. Microbiologyopen. 2012;1(3):268–75. pmid:23170226
View Article
PubMed/NCBI
Google Scholar

[106] View Article

[107] PubMed/NCBI

[108] Google Scholar

[ref29] 29. Ling H, Saeidi N, Rasouliha BH, Chang MW. A predicted S-type pyocin shows a bactericidal activity against clinical Pseudomonas aeruginosa isolates through membrane damage. FEBS Lett. 2010;584(15):3354–8. pmid:20580355
View Article
PubMed/NCBI
Google Scholar

[110] View Article

[111] PubMed/NCBI

[112] Google Scholar

[ref30] 30. Dingemans J, Ghequire MG, Craggs M, De Mot R, Cornelis P. Identification and functional analysis of a bacteriocin, pyocin S6, with ribonuclease activity from a Pseudomonas aeruginosa cystic fibrosis clinical isolate. Microbiologyopen. 2016. 5(3):413–23. pmid:26860427.
View Article
PubMed/NCBI
Google Scholar

[114] View Article

[115] PubMed/NCBI

[116] Google Scholar

[ref31] 31. Bragonzi A, Paroni M, Nonis A, Cramer N, Montanari S, Rejman J, et al. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. American journal of respiratory and critical care medicine. 2009;180(2):138–45. pmid:19423715
View Article
PubMed/NCBI
Google Scholar

[118] View Article

[119] PubMed/NCBI

[120] Google Scholar

[ref32] 32. Qiu D, Damron FH, Mima T, Schweizer HP, Yu HD. PBAD-based shuttle vectors for functional analysis of toxic and highly regulated genes in Pseudomonas and Burkholderia spp. and other bacteria. Appl Environ Microbiol. 2008;74(23):7422–6. pmid:18849445
View Article
PubMed/NCBI
Google Scholar

[122] View Article

[123] PubMed/NCBI

[124] Google Scholar

[ref33] 33. Delvillani F, Sciandrone B, Peano C, Petiti L, Berens C, Georgi C, et al. Tet-Trap, a genetic approach to the identification of bacterial RNA thermometers: application to Pseudomonas aeruginosa. RNA. 2014;20(12):1963–76. pmid:25336583
View Article
PubMed/NCBI
Google Scholar

[126] View Article

[127] PubMed/NCBI

[128] Google Scholar

[ref34] 34. Corcoran CP, Podkaminski D, Papenfort K, Urban JH, Hinton JC, Vogel J. Superfolder GFP reporters validate diverse new mRNA targets of the classic porin regulator, MicF RNA. Mol Microbiol. 2012;84(3):428–45. pmid:22458297
View Article
PubMed/NCBI
Google Scholar

[130] View Article

[131] PubMed/NCBI

[132] Google Scholar

[ref35] 35. Popat R, Crusz SA, Messina M, Williams P, West SA, Diggle SP. Quorum-sensing and cheating in bacterial biofilms. Proc Biol Sci. 2012;279(1748):4765–71. pmid:23034707
View Article
PubMed/NCBI
Google Scholar

[134] View Article

[135] PubMed/NCBI

[136] Google Scholar

[ref36] 36. Martinez-Garcia E, de Lorenzo V. Engineering multiple genomic deletions in Gram-negative bacteria: analysis of the multi-resistant antibiotic profile of Pseudomonas putida KT2440. Environ Microbiol. 2011;13(10):2702–16. pmid:21883790
View Article
PubMed/NCBI
Google Scholar

[138] View Article

[139] PubMed/NCBI

[140] Google Scholar

[ref37] 37. Horton RM, Hunt HD, Ho SN, Pullen JK, Pease LR. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene. 1989;77(1):61–8. pmid:2744488
View Article
PubMed/NCBI
Google Scholar

[142] View Article

[143] PubMed/NCBI

[144] Google Scholar

[ref38] 38. Fyfe JA, Harris G, Govan JR. Revised pyocin typing method for Pseudomonas aeruginosa. J Clin Microbiol. 1984;20(1):47–50. pmid:6430955
View Article
PubMed/NCBI
Google Scholar

[146] View Article

[147] PubMed/NCBI

[148] Google Scholar

[ref39] 39. Cigana C, Curcuru L, Leone MR, Ierano T, Lore NI, Bianconi I, et al. Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection. PLoS One. 2009;4(12):e8439. pmid:20037649
View Article
PubMed/NCBI
Google Scholar

[150] View Article

[151] PubMed/NCBI

[152] Google Scholar

[ref40] 40. Winsor GL, Griffiths EJ, Lo R, Dhillon BK, Shay JA, Brinkman FS. Enhanced annotations and features for comparing thousands of Pseudomonas genomes in the Pseudomonas genome database. Nucleic Acids Res. 2016; 44(D1):D646–53. pmid:26578582
View Article
PubMed/NCBI
Google Scholar

[154] View Article

[155] PubMed/NCBI

[156] Google Scholar

[ref41] 41. Cigana C, Lore NI, Riva C, De Fino I, Spagnuolo L, Sipione B, et al. Tracking the immunopathological response to Pseudomonas aeruginosa during respiratory infections. Sci Rep. 2016;6:21465. pmid:26883959
View Article
PubMed/NCBI
Google Scholar

[158] View Article

[159] PubMed/NCBI

[160] Google Scholar

[ref42] 42. Kukavica-Ibrulj I, Bragonzi A, Paroni M, Winstanley C, Sanschagrin F, O'Toole GA, et al. In vivo growth of Pseudomonas aeruginosa strains PAO1 and PA14 and the hypervirulent strain LESB58 in a rat model of chronic lung infection. Journal of bacteriology. 2008;190(8):2804–13. pmid:18083816
View Article
PubMed/NCBI
Google Scholar

[162] View Article

[163] PubMed/NCBI

[164] Google Scholar

[ref43] 43. Tjaden B. TargetRNA: a tool for predicting targets of small RNA action in bacteria. Nucleic Acids Res. 2008;36.
View Article
Google Scholar

[166] View Article

[167] Google Scholar

[ref44] 44. Wright PR, Georg J, Mann M, Sorescu DA, Richter AS, Lott S, et al. CopraRNA and IntaRNA: predicting small RNA targets, networks and interaction domains. Nucleic Acids Res. 2014;42.
View Article
Google Scholar

[169] View Article

[170] Google Scholar

[ref45] 45. Busch A, Richter AS, Backofen R. IntaRNA: efficient prediction of bacterial sRNA targets incorporating target site accessibility and seed regions. Bioinformatics. 2008;24(24):2849–56. pmid:18940824
View Article
PubMed/NCBI
Google Scholar

[172] View Article

[173] PubMed/NCBI

[174] Google Scholar

[ref46] 46. Abdi-Ali A, Worobec EA, Deezagi A, Malekzadeh F. Cytotoxic effects of pyocin S2 produced by Pseudomonas aeruginosa on the growth of three human cell lines. Can J Microbiol. 2004;50(5):375–81. pmid:15213746
View Article
PubMed/NCBI
Google Scholar

[176] View Article

[177] PubMed/NCBI

[178] Google Scholar

Figures

Abstract

Introduction

Materials and methods

Ethics Statement

Bacterial strains and culture conditions

Plasmid constructions and mutant generations

RNA isolation and analysis

In vitro and vivo assays of sRNA/mRNA interactions

RNA synthesis

Pyocin S3 spotting assay

Antibiotic disk diffusion

UV sensitivity assay

Cytotoxicity assays in human CF respiratory cells

Bacterial isolates analysis

Results

The sRNA PesA is encoded in the PAPI-1 and is a processed transcript

PesA is widespread expressed in clinical and environmental isolates

PesA is induced in anaerobic growth and at 37°C

PesA is involved in ciprofloxacin and UV-resistance

PesA is involved in P. aeruginosa pathogenicity in human CF respiratory cells

PesA targets pyoS3A-I operon

Discussion

Supporting information

S1 Fig. Validation of PesA deletion and overexpression.

S2 Fig. Fluorescence activity to check PesA regulation on the leader of pyoS3A gene, and spurious outside interactions of PesA with sfGFP and mCherry open reading frames.

S1 Table. Clinical isolates.

S2 Table. Strains and plasmids.

S3 Table. Oligonucleotides.

S4 Table. List of mRNA targets of PesA predicted by bioinformatics analysis conducted with the TargetRNA web-tool.

S5 Table. Quantitative RT-PCR analyses of pyoS3A and pyoS3I mRNA levels in wild-type and ΔpesA backgrounds.

Acknowledgments

Author Contributions

References